PRECLINICAL RETT SYNDROME STUDIES
Advancing pioneering therapies for this rare neurodevelopmental condition.
PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR RETT SYNDROME PROGRAM.
MODELS / SERVICES
Be confident in your data:
- Our scientific staff average 15+ years of experience
- FDA Part 11 compliant
- Rigorous adherence to international GLP and QA best practices
- AAALAC accredited
- 600+ NDAs based on our data
Advance to NDA quickly and confidently. Contact PharmaLegacy today.
We’re ready when you are.
Tell us your Rett Syndrome pipeline challenges.
